Emergent Biosolutions
(EBS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2014 | 03-2014 | 12-2013 | 09-2013 | 06-2013 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 168,130 | 160,215 | 179,338 | 172,561 | 156,243 |
| Receivables | 94,944 | 80,738 | 66,238 | 30,681 | 60,871 |
| Inventories | 66,030 | 71,268 | 14,643 | 16,325 | 18,582 |
| Income taxes - deferred | N/A | N/A | N/A | 1,264 | 1,264 |
| TOTAL | $345,449 | $327,203 | $273,115 | $234,015 | $248,159 |
| Non-Current Assets | |||||
| PPE Net | 302,455 | 303,468 | 264,240 | 263,056 | 248,504 |
| Intangibles | 113,866 | 116,116 | 44,102 | 45,065 | 5,502 |
| Other Non-Current Assets | 75,479 | 76,464 | 45,173 | 53,328 | 53,449 |
| TOTAL | $491,800 | $496,048 | $353,515 | $361,449 | $307,455 |
| Total Assets | $837,249 | $823,251 | $626,630 | $595,464 | $555,614 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 4,470 | 4,470 |
| Accounts payable and accrued liabilities | 36,968 | 36,643 | 27,521 | 29,018 | 25,711 |
| Accrued Expenses | 26,001 | 23,121 | 25,867 | 19,780 | 16,548 |
| Other current liabilities | 8,037 | 7,292 | 1,341 | 1,326 | N/A |
| TOTAL | $76,427 | $72,324 | $56,651 | $56,632 | $48,778 |
| Non-Current Liabilities | |||||
| Long Term Debt | 251,000 | 251,000 | 62,000 | 54,952 | 56,069 |
| Deferred Revenues | 5,333 | 5,180 | 1,834 | 2,038 | 2,049 |
| Other Non-Current Liabilities | 20,423 | 20,627 | 17,400 | 17,023 | 1,813 |
| TOTAL | $273,055 | $273,432 | $80,814 | $71,975 | $57,754 |
| Total Liabilities | $349,482 | $345,756 | $137,465 | $128,607 | $106,532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,477 | 37,411 | 36,772 | 36,367 | 36,270 |
| Common Shares | 38 | 38 | 37 | 37 | 36 |
| Retained earnings | 236,321 | 231,292 | 251,528 | 236,305 | 222,814 |
| Other shareholders' equity | -3,370 | -3,510 | -4,037 | -3,857 | -3,867 |
| TOTAL | $487,767 | $477,495 | $489,165 | $466,857 | $449,082 |
| Total Liabilities And Equity | $837,249 | $823,251 | $626,630 | $595,464 | $555,614 |